{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:54Z","timestamp":1786993734020,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["ZD2021028"],"award-info":[{"award-number":["ZD2021028"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.lfs.2025.123646","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T08:24:17Z","timestamp":1744878257000},"page":"123646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["N6-methyladenosine-modified circQKI inhibits prostate cancer docetaxel-sensitivity via miR-188-3p\/Beclin-1 pathway"],"prefix":"10.1016","volume":"372","author":[{"given":"Tong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2025.123646_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2025.123646_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Nat. Cancer Center"},{"key":"10.1016\/j.lfs.2025.123646_bb0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2025.123646_bb0020","article-title":"Intensification approaches and treatment sequencing in metastatic castration-resistant prostate Cancer: a systematic review","author":"Francini","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.lfs.2025.123646_bb0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.eururo.2024.03.036","volume":"86","author":"Saad","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.lfs.2025.123646_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s13046-021-02149-5","article-title":"CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation","volume":"40","author":"Liu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2025.123646_bb0035","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2147\/DDDT.S300376","article-title":"Exosomal Circ-XIAP promotes docetaxel resistance in prostate Cancer by regulating miR-1182\/TPD52 Axis","volume":"15","author":"Zhang","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.lfs.2025.123646_bb0040","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41419-021-04015-w","article-title":"Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer","volume":"12","author":"Zhong","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.123646_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","article-title":"CircRNA in cancer: fundamental mechanism and clinical potential","volume":"505","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2025.123646_bb0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12943-020-01246-x","article-title":"CircRNA inhibits DNA damage repair by interacting with host gene","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2025.123646_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109828","article-title":"CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p\/ABCC1 axis","volume":"124","author":"Zheng","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2025.123646_bb0060","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41592-023-01945-5","article-title":"Circular RNA detection pipelines yield divergent sets of circular RNAs","volume":"20","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.lfs.2025.123646_bb0065","series-title":"Circular RNAs: Diversity of Form and Function, RNA (New York, N.Y.)","first-page":"1829","volume":"20","author":"Lasda","year":"2014"},{"key":"10.1016\/j.lfs.2025.123646_bb0070","article-title":"The important regulatory roles of circRNA-encoded proteins or peptides in cancer pathogenesis (review)","volume":"64","author":"Zhang","year":"2024","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2025.123646_bb0075","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/iub.2915","article-title":"CircSLC4A7 in resistant-cells-derived exosomes promotes docetaxel resistance via the miR-1205\/MAPT axis in prostate cancer","volume":"76","author":"Lin","year":"2024","journal-title":"IUBMB Life"},{"key":"10.1016\/j.lfs.2025.123646_bb0080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2019.10.006","article-title":"Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel","volume":"468","author":"Shen","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2025.123646_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217230","article-title":"A tumor-promotional molecular axis CircMAPKBP1\/miR-17-3p\/TGF\u03b22 activates autophagy pathway to drive tongue squamous cell carcinoma cisplatin chemoresistance","volume":"604","author":"Xie","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2025.123646_bb0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s11658-024-00571-z","article-title":"Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective","volume":"29","author":"Wang","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.lfs.2025.123646_bb0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12943-020-01152-2","article-title":"Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression","volume":"19","author":"Liang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2025.123646_bb0100","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.7150\/thno.33282","article-title":"KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy","volume":"9","author":"Jia","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2025.123646_bb0105","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41420-024-02185-y","article-title":"Non-canonical translation in cancer: significance and therapeutic potential of non-canonical ORFs, m(6)A-modification, and circular RNAs","volume":"10","author":"Deng","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.123646_bb0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/0113892029296712240405053201","article-title":"Ramifications of m6A modification on ncRNAs in Cancer","volume":"25","author":"Mehmood","year":"2024","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.lfs.2025.123646_bb0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13046-024-03136-2","article-title":"Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects","volume":"43","author":"Tang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2025.123646_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s11658-024-00628-z","article-title":"METTL3-mediated m(6)a modification of circGLIS3 promotes prostate cancer progression and represents a potential target for ARSI therapy","volume":"29","author":"Cheng","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.lfs.2025.123646_bb0125","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/bab.2631","article-title":"Regulation of hsa_circ_0112136 by m6A demethylase FTO can enhance the malignancy of gastric cancer via the regulation of the PI3K\/AKT\/mTOR pathway","volume":"71","author":"Liu","year":"2024","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.lfs.2025.123646_bb0130","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1186\/s12967-024-05498-9","article-title":"CircRHBDD1 promotes immune escape via IGF2BP2\/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2025.123646_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112485","article-title":"CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2\/CD36 pathway","volume":"137","author":"Li","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2025.123646_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100886","article-title":"N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells","volume":"65","author":"Liu","year":"2022","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.lfs.2025.123646_bb0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40364-022-00393-1","article-title":"circCYP24A1 promotes docetaxel resistance in prostate Cancer by upregulating ALDH1A3","volume":"10","author":"Yin","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.lfs.2025.123646_bb0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.canlet.2019.11.014","article-title":"FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK\/mTOR-mediated autophagy","volume":"469","author":"Lin","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2025.123646_bb0155","series-title":"Rajewsky, circBase: A Database for Circular RNAs, RNA (New York, N.Y.)","first-page":"1666","volume":"20","author":"Gla\u017ear","year":"2014"},{"key":"10.1016\/j.lfs.2025.123646_bb0160","doi-asserted-by":"crossref","first-page":"34985","DOI":"10.1038\/srep34985","article-title":"circRNADb: a comprehensive database for human circular RNAs with protein-coding annotations","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2025.123646_bb0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15476286.2015.1128065","article-title":"CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs","volume":"13","author":"Dudekula","year":"2016","journal-title":"RNA Biol."},{"key":"10.1016\/j.lfs.2025.123646_bb0170","doi-asserted-by":"crossref","first-page":"W451","DOI":"10.1093\/nar\/gkl243","article-title":"RNAhybrid: microRNA target prediction easy, fast and flexible","volume":"34","author":"Kr\u00fcger","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2025.123646_bb0175","doi-asserted-by":"crossref","first-page":"1506426","DOI":"10.3389\/fimmu.2024.1506426","article-title":"Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment","volume":"15","author":"Cao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123646_bb0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s42003-024-05890-7","article-title":"BECLIN1 is essential for intestinal homeostasis involving autophagy-independent mechanisms through its function in endocytic trafficking","volume":"7","author":"Tran","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.lfs.2025.123646_bb0185","doi-asserted-by":"crossref","unstructured":"M. Shelley, C. Harrison, B. Coles, J. Staffurth, T.J. Wilt, M.D. Mason, Chemotherapy for hormone-refractory prostate cancer, The Cochrane database of systematic reviews. (2006) Cd005247. doi:https:\/\/doi.org\/10.1002\/14651858.CD005247.pub2.","DOI":"10.1002\/14651858.CD005247.pub2"},{"key":"10.1016\/j.lfs.2025.123646_bb0190","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.eururo.2013.08.007","article-title":"Initial biopsy Gleason score as a predictive marker for survival benefit in patients with castration-resistant prostate cancer treated with docetaxel: data from the TAX327 study","volume":"66","author":"van Soest","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.lfs.2025.123646_bb0195","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41419-024-07246-9","article-title":"Androgen-targeted hsa_circ_0085121 encodes a novel protein and improves the development of prostate cancer through facilitating the activity of PI3K\/Akt\/mTOR pathway and enhancing AR-V7 alternative splicing","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.123646_bb0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-023-01452-2","article-title":"Exosomal circRNA: emerging insights into cancer progression and clinical application potential","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.lfs.2025.123646_bb0205","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13046-022-02404-3","article-title":"Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism","volume":"41","author":"Chen","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2025.123646_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3403","article-title":"Silencing of circDPP4 suppresses cell progression of human prostate cancer and enhances docetaxel cytotoxicity through regulating the miR-564\/ZIC2 axis","volume":"24","author":"Gu","year":"2022","journal-title":"J. Gene Med."},{"key":"10.1016\/j.lfs.2025.123646_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100915","article-title":"Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy","volume":"67","author":"Yu","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.lfs.2025.123646_bb0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13578-020-00494-0","article-title":"Mesenchymal stem cells desensitize castration-resistant prostate cancer to docetaxel chemotherapy via inducing TGF-\u03b21-mediated cell autophagy","volume":"11","author":"Yu","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.lfs.2025.123646_bb0225","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41419-018-0866-5","article-title":"Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells","volume":"9","author":"Cristofani","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.123646_bb0230","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525002814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525002814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T08:58:37Z","timestamp":1749200317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525002814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":46,"alternative-id":["S0024320525002814"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123646","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N6-methyladenosine-modified circQKI inhibits prostate cancer docetaxel-sensitivity via miR-188-3p\/Beclin-1 pathway","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123646"}}